Impacts of a navigation program based on health information technology for patients receiving oral anticancer therapy: the CAPRI randomized controlled trial-Reference-Cited by-同舟云学术

Impacts of a navigation program based on health information technology for patients receiving oral anticancer therapy: the CAPRI randomized controlled trial

Published:2017-02-13 Issue:1 Volume:17 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Gervès-Pinquié Chloé^ORCID,Daumas-Yatim Fatima,Lalloué Benoît,Girault Anne,Ferrua Marie,Fourcade Aude,Lemare François,Dipalma Mario,Minvielle Etienne

Funder

French National Research Agency

Foundation Philanthropia Lombard Odier.

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12913-017-2066-x.pdf

Reference60 articles.

1. Thanki K, Gangwal RP, Sangamwar AT, Jain S. Oral delivery of anticancer drugs: Challenges and opportunities. J Controlled Release. 2013;170:15–40.

2. Agboola S, Flanagan C, Searl M, Elfiky A, Kvedar J, Jethwani K. Improving outcomes in cancer patients on oral anti-cancer medications using a novel mobile phone-based intervention: study design of a randomized controlled trial. JMIR Res Protoc. 2014;3:e79.

3. Spoelstra SL, Given BA, Given CW, Grant M. Policy Implications of Oral Agents. Semin Oncol Nurs. 2011;27:161–5.

4. Spoelstra SL, Given CW. Assessment and Measurement of Adherence to Oral Antineoplastic Agents. Semin Oncol Nurs. 2011;27:116–32.

5. Spoelstra SL, Given BA, Given CW, Grant M, Sikorskii A, You M, et al. An Intervention to Improve Adherence and Management of Symptoms for Patients Prescribed Oral Chemotherapy Agents: An Exploratory Study. Cancer Nurs. 2013;36:18–28.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial;The European Journal of Health Economics;2024-06-28

2. Perspectives on seamless collaboration between primary and secondary care for oral anticancer treatments;Journal of Interprofessional Care;2023-01-04

3. The Ambulatory Medical Assistance (AMA) programme during active‐phase treatment in patients with haematological malignancies: A cost‐effectiveness analysis;European Journal of Cancer Care;2022-09-27

4. Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial;Nature Medicine;2022-04-25

5. The effect of navigation programme on the management of symptoms related to head and neck radiotherapy;Transplant Immunology;2021-12